A detailed history of Ameriprise Financial Inc transactions in Beyond Air, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 10,600 shares of XAIR stock, worth $5,724. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,600
Previous 10,600 -0.0%
Holding current value
$5,724
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$2.31 - $4.18 $11,550 - $20,900
-5,000 Reduced 32.05%
10,600 $24,000
Q2 2023

Aug 14, 2023

SELL
$4.26 - $6.92 $8,520 - $13,840
-2,000 Reduced 11.36%
15,600 $66,000
Q3 2022

Nov 14, 2022

BUY
$7.42 - $11.39 $1,484 - $2,278
200 Added 1.15%
17,600 $131,000
Q2 2022

Aug 15, 2022

SELL
$4.96 - $7.83 $10,569 - $16,685
-2,131 Reduced 10.91%
17,400 $116,000
Q1 2022

May 16, 2022

SELL
$6.33 - $9.53 $18,135 - $27,303
-2,865 Reduced 12.79%
19,531 $131,000
Q4 2021

Feb 14, 2022

SELL
$8.44 - $15.61 $738,922 - $1.37 Million
-87,550 Reduced 79.63%
22,396 $211,000
Q3 2021

Nov 15, 2021

SELL
$5.9 - $12.54 $30,668 - $65,182
-5,198 Reduced 4.51%
109,946 $1.22 Million
Q2 2021

Aug 16, 2021

BUY
$4.72 - $7.15 $56,984 - $86,321
12,073 Added 11.71%
115,144 $746,000
Q1 2021

May 17, 2021

SELL
$5.13 - $7.24 $256,340 - $361,775
-49,969 Reduced 32.65%
103,071 $567,000
Q4 2020

Feb 12, 2021

SELL
$5.18 - $6.03 $37,715 - $43,904
-7,281 Reduced 4.54%
153,040 $807,000
Q3 2020

Nov 16, 2020

SELL
$4.86 - $7.07 $1.18 Million - $1.71 Million
-242,081 Reduced 60.16%
160,321 $832,000
Q2 2020

Aug 14, 2020

BUY
$6.44 - $9.45 $293,406 - $430,541
45,560 Added 12.77%
402,402 $3.23 Million
Q1 2020

May 15, 2020

BUY
$3.94 - $10.93 $1.41 Million - $3.9 Million
356,842 New
356,842 $2.84 Million

Others Institutions Holding XAIR

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $16.1M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.